Abstract: Objective To investigate the correlation between the progress of liver fibrosis and evolution of serum virology indicators. Methods Total of 468 patients with chronic hepatitis B were included in our study. Three groups (S0-1, S2, S3-4) were divided according to the liver fibrosis stages and the relationship
between liver fibrosis stages and expression levels of HBeAg as well as HBV DNA levels were analyzed respectively. Results With the progress of liver fibrosis (S0-S1→S2→S3-S4), the positive proportion of HBeAg was gradually decreased (60.00% > 23.25% > 16.75%). Contrarily, the negative percentage
of HBeAg presented with an increased trend (23.53% < 33.82% < 42.65%) and the differences were of statistical significant (χ2 = 35.756,P < 0.001). HBV DNA levels were different among patients with different stages of liver fibrosis (χ2 = 58.790,P < 0.001). With the progress of liver fibrosis, HBV DNA
levels showed a declined trend (r = -0.343). Differences between liver fibrosis stages and HBV DNA copies in CHB patients with positive expression of HBeAg were also of statistical significant (χ2 = 38.011,P <0.001). In addition, HBV DNA levels and liver fibrosis stages were also presented with a negative correlation (r = 0.290). Conclusions With the progress of liver fibrosis (S0-S1→S2→S3-S4), positive proportions of HBeAg and HBV DNA levels both manifested a gradually declined trend. Similarly characteristics were detected in CHB patients with persistently positive expression of HBeAg.
|